PEOPLE - Canada Foundation for Innovation makes appointment:
This article was originally published in Clinica
Eliot Phillipson has been appointed president and CEO of the Canada Foundation for Innovation (CFI). He succeeds Dr David Strangway, who retires at the end of March, after six years. Dr Phillipson will take up his appointment on July 1; in the interim, senior vice-president Dr Carmen Charette will serve as acting president. Dr Phillipson, a medical doctor with specialist experience in internal medicine, cardiovascular research and respiration, will be responsible for a Can$3.65bn (US$2.79bn) annual budget to "strengthen the capacity of Canadian universities, research hospitals and other non-profit organisations to carry out world-class technology R&D".
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.